SOURCES SOUGHT
A -- RFI: R&D Study: A novel adjuvant to enhance the immunogenicity of a tetravalent dengue purified inactivated vaccine in non-humans primates
- Notice Date
- 3/18/2021 8:22:29 AM
- Notice Type
- Sources Sought
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NAVAL MEDICAL LOGISTICS COMMAND FORT DETRICK MD 21702-9203 USA
- ZIP Code
- 21702-9203
- Solicitation Number
- NHPStudy18Mar21
- Response Due
- 3/31/2021 7:00:00 AM
- Archive Date
- 04/15/2021
- Point of Contact
- Christine Russman, Phone: 3016190727
- E-Mail Address
-
christine.l.russman.civ@mail.mil
(christine.l.russman.civ@mail.mil)
- Description
- Naval Medical Logistics Command�on behalf of the Naval Medical Research Center�is requesting information from contractors capable of conducting a non-human primate (NHP) study using a dengue tetravalent purified inactivated vaccine (TPIV) with a novel adjuvant, and then challenge non-human primates (NHPs) with wild type viruses to evaluate enhanced immunogenicity and efficacy.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/f588d47a97a849e783b877844b7d3901/view)
- Record
- SN05947455-F 20210320/210318230113 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |